Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Patient with rare bleeding disorder becomes first to test new treatment

22
May 2024

The thousands of patients who participate in Richmond’s trials are helping to advance medical science and save lives and, in the process, some make history. In a film released today, one trial participant tells her story.

View Articles

Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations

30
April 2024

Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.

View Articles

Announcement of Jorg Becoming President Elect

22
April 2024

Richmond Pharmacology announces CEO Dr. Jorg Taubel's appointment as President Elect of Germany's AGAH, where he will enhance early-phase clinical research over a six-year term.

View Articles

Single-dose gene silencing cure for fatal heart disease comes one step closer

20
March 2024

Richmond is delighted to be part of the first large-scale in-human trial of a genetic cure for ATTR Amyloidosis

View Articles

Ensuring The Future Of The Experienced Investigator Is Ingrained In Good Clinical Practice Guidance

3
January 2024

The ICH Expert Working Group has been revising the Good Clinical Practice (GCP) guideline, ICH E6 (GCP) R3.

View Articles

Powering STEM Dreams: Snowsfield's Exciting Tour of Richmond Pharmacology

18
December 2023

Richmond Pharmacology recently welcomed STEM leaders from Snowsfield Primary School, marking a follow-up to our donation of STEM books for their library.

View Articles

Latest news

Regulatory Pathways to Success

January 9, 2026
Structured pathways to accelerate development and approval.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event